Status:

COMPLETED

Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia

Lead Sponsor:

B.P. Koirala Institute of Health Sciences

Collaborating Sponsors:

University Grants Commission

Conditions:

Herpes Zoster

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

All eligible Herpes Zoster patients will be randomized into two groups. Group 1 will be the treatment group receiving Pregabalin 75 mg twice daily for 4 weeks in addition to other routine treatment. W...

Detailed Description

This study wants to see the role of Pregabalin in acute herpetic neuralgia pain reduction and for the prevention of post herpetic neuralgia incidence as compared to placebo group. For this purpose, al...

Eligibility Criteria

Inclusion

  • Patients of HZ presenting within 72 hours of onset of rash,
  • With pain score 40 or above on 100 mm pain Visual Analogue Scale at the screening visit,
  • Giving written consent for the study.
  • Age between 18-70 years

Exclusion

  • HZ presenting after 72 hours of onset
  • Pain score less than 40 at baseline
  • Who took the stable doses of oral analgesics like: NSAIDs, acetaminophen, opioids and antidepressant within six hours of screening visit
  • Using Pregabalin and Gabapentin within last 72 hours
  • Nerve block therapy within the last 48 hours
  • History of hypersensitivity to the drug or its ingredients
  • Use of topical medications within 12 hours
  • Unable to come for follow up because of severe systemic illness
  • Significant hepatic and renal disease,
  • Bed ridden patients or those who are physically unfit for follow up visits.
  • Ethically considered vulnerable members- pregnant/lactating mothers/newborn/children below 12 years /physically or mentally challenged individuals/HIV/ AIDS/IV drug users

Key Trial Info

Start Date :

July 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2019

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT03809702

Start Date

July 15 2018

End Date

December 30 2019

Last Update

October 14 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

B P Koirala Institute of Health Sciences

Dharān, Koshi, Nepal, 7053